Expertise in
30
conditions

Dr. Hugh D. Moulding

Neurosurgery
St. Luke's Neurosurgical Associates-Bethlehem
701 Ostrum St Ste 602, 
Fountain Hill, PA 
Offers Telehealth
Expertise in
30
conditions
St. Luke's Neurosurgical Associates-Bethlehem
701 Ostrum St Ste 602, 
Fountain Hill, PA 

Overview

Hugh Moulding is a Neurosurgery provider practicing medicine in Fountain Hill, Pennsylvania.

Dr. Moulding is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Metastatic Brain Tumor, Awake Craniotomy, and Balloon Sinuplasty.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials.

Specialties

Neurosurgery

Licenses

Neurological Surgery in PA

Hospital Affiliations

St Luke's Hospital - Monroe Campus
Geisinger St. Luke's Hospital
St Luke's Hospital - Upper Bucks Campus
St Luke's Warren Hospital
St Lukes Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

St. Luke's Neurosurgical Associates-Bethlehem
701 Ostrum St Ste 602, Fountain Hill, PA 18015
Other Locations
St. Luke's Neurosurgical Associates-Easton
1700 St Lukes Blvd Ste 200, Easton, PA 18045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
Enrollment Status: Completed
Publish Date: February 25, 2019
Intervention Type: Drug, Procedure
View 2 Less Clinical Trials

2 Total Publications

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.
Journal: Cell reports. Medicine
Published: September 14, 2022
Similar Doctors
Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Vickie And Jack Farber Institute For Neuroscience At Jefferson

380 North Oxford Valley Road, 
Langhorne, PA 
 (38.2 miles away)
215-757-3980
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pascal Jabbour is a Neurosurgery provider practicing medicine in Langhorne, Pennsylvania. Dr. Jabbour is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Stroke, Subarachnoid Hemorrhage, Thrombectomy, and Stent Placement. Dr. Jabbour is board certified in American Board Of Neurological Surgery and Neurological Surgery. Dr. Jabbour is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required
Before you request

Vickie And Jack Farber Institute For Neuroscience At Jefferson

380 North Oxford Valley Road, 
Langhorne, PA 
 (38.2 miles away)
215-757-3980
Languages Spoken:
English, Greek
See accepted insurances
Accepting New Patients
Offers Telehealth

Stavropoula Tjoumakaris is a Neurosurgery provider practicing medicine in Langhorne, Pennsylvania. Dr. Tjoumakaris is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Brain Aneurysm, Stroke, Subarachnoid Hemorrhage, Stent Placement, and Thrombectomy. Dr. Tjoumakaris is board certified in American Board Of Neurological Surgery and Neurological Surgery. Dr. Tjoumakaris is currently accepting new patients.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required
Before you request

Penn Gamma Knife Center

801 Spruce Street, Spruce Building, 1st Floor, 
Philadelphia, PA 
 (45.6 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald O'rourke is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania. Dr. O'rourke is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy. Dr. O'rourke is board certified in Neurological Surgery, 1998. Dr. O'rourke is currently accepting new patients.

Frequently Asked Questions about Dr. Hugh D. Moulding

How do I make an appointment with Dr. Hugh D. Moulding?

You can book an appointment with Dr. Hugh D. Moulding by calling their office at 484-526-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hugh D. Moulding a top-rated expert for Primitive Neuroectodermal Tumor (PNET)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hugh D. Moulding is classified as an Distinguished expert for Primitive Neuroectodermal Tumor (PNET), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hugh D. Moulding specialize in?

While Dr. Hugh D. Moulding is a Neurosurgery, they have specific expertise in Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Hugh D. Moulding participate in research or clinical trials?

Yes. Dr. Hugh D. Moulding has published 2 articles and abstracts on conditions like Primitive Neuroectodermal Tumor (PNET). You can view a list of Dr. Hugh D. Moulding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Hugh D. Moulding accept my insurance?

Dr. Hugh D. Moulding accepts most major insurance plans, including Capital Blue Cross and Cigna. We recommend calling the office directly at 484-526-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moulding's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile